InvestorsHub Logo
Followers 468
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Tuesday, 07/12/2011 8:49:06 AM

Tuesday, July 12, 2011 8:49:06 AM

Post# of 724
NuPathe(PATH_)
The event: FDA approval decision for the migraine patch Zelrix.
The timeline: FDA is expected to make its approval decision on Aug. 29.
The stakes: If approved, Zelrix would be NuPathe's first commercially marketed product. Zelrix is a battery-operated patch that pushes a steady stream of the commonly used migraine medicine sumatriptan through the skin and into the patient's bloodstream.

http://www.thestreet.com/story/11180428/2/more-hot-biotech-trades-for-second-half-2011.html


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PATH News